The global biomarkers market was valued at $46.4 billion in 2023, and is projected to reach $134.2 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
Report Summary
The scope of the report focuses on the potential industry players operating in the Predisposition biomarkers market and their relative share. In addition, it provides in-depth analysis of the market, outlining the company profiles,
The global immunology market was valued at $110.1 billion in 2023, and is projected to reach $204.0 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033
